Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | SCN1A | P35498 | 1/20 | 0.50 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.50 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL894817 | 0.80 | HRH1 (0.73) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL8812539 | 0.80 | HRH1 (0.73) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL8812545 | 0.80 | HRH1 (0.73) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL7319884 | 0.79 | CYP2D6 (0.64) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL10306736 | 0.78 | CYP2D6 (0.48) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL9518037 | 0.78 | CYP2D6 (0.48) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| Hydrochloric Acid SCHEMBL7321768 | 0.78 | CYP2D6 (0.62) | MEN1CYP2D6LMNAKMT2AHRH1 | |
| SCHEMBL20175849 | 0.76 | TSHR (0.42) | MEN1KMT2AHRH1CHRM3CYP1A2 | |
| SCHEMBL16799524 | 0.76 | KIF11 (0.37) | MEN1KMT2ANFE2L2CYP1A2CYP2C19 | |
| SCHEMBL5862698 | 0.76 | CYP19A1 (0.53) | MEN1LMNAKMT2ACHRM3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2436665-B1 | PROCESS FOR PRODUCING VINYL ETHER | NIPPON CARBIDE KOGYO KK (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-9000228-B2 | Method for producing vinyl ether | NIPPON CARBIDE INDUSTRIES CO., LTD. (JP) | 2015-04-07 | — | — | US | disclosed |
| US-20120083628-A1 | METHOD FOR PRODUCING VINYL ETHER | NIPPON CARBIDE INDUSTRIES CO., INC. (JP) | 2012-04-05 | — | — | US | disclosed |
| EP-0774470-A1 | Process for the polymerisation of olefins in the presence of an aluminium organic derivative | ELF ATOCHEM S.A. (FR) | 1997-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083628-A1 | METHOD FOR PRODUCING VINYL ETHER | AGXT, CYP2E1, TGM1 | MEN1 3337/4885CYP2D6 951/4885LMNA 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.